EUVIMEDEUVIMED entdecken
BeobachtungsstudieZurückgezogene PublikationOpen Access

The Long-term Lung and Respiratory Outcomes of Acid Sphingomyelinase Deficiency: A 10- and 20-year Follow-up Study

Yu-Nan Huang, Shang-Lun Chiang, Jing-Yang Huang, Wen-Li Lu, DA-Tian Bau, Pen-Hua Su, Chung-Hsing Wang

In Vivo · 2024

DOI: 10.21873/invivo.13457 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift In Vivo, 2024. Verfasst von Yu-Nan Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Niemann-Pick Disease, Type A, Niemann-Pick Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Acid sphingomyelinase deficiency (ASMD) is a rare lysosomal storage disorder characterized by sphingomyelin accumulation causing progressive lung disease, respiratory failure, and death. PATIENTS AND METHODS: This retrospective observational study used the TriNetX database of electronic health records for 15,108 patients with ASMD from 2000-2020. After exclusions, 8,980 individuals were followed for 10 or 20 years. Outcomes included incidence and prevalence of respiratory disorders. Associations of age, sex and race were assessed. RESULTS: Nearly all respiratory outcomes increased significantly over 20 versus 10 years. Other respiratory disorders, specified respiratory disorders and secondary pulmonary hypertension exhibited the greatest increases, reflecting progressive lung damage in ASMD. While outcomes were poor overall, older age, male sex, and racial minority status associated with greater risks, indicating differences in disease progression or care. CONCLUSION: This study confirms the progressive nature of ASMD and need for close monitoring and treatment of pulmonary complications to reduce long-term morbidity and mortality. Genetic testing enabling diagnosis even for milder, adult-onset forms is critical to optimize outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Niemann-Pick Disease, Type ANiemann-Pick DiseasesAdultHumansMaleFollow-Up StudiesSphingomyelin PhosphodiesteraseLung

Stichwörter der Autor:innen

Acid sphingomyelinase deficiencyacid sphingomyelinaseobstructive lung diseaseperipheral neuropathypulmonary hypertension

Substanzen

Sphingomyelin Phosphodiesterase

Autor:innen und Institutionen

  • Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan, R.O.C.
  • School of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.
  • Department of Medical Laboratory Science, College of Medical Science and Technology, I-Shou University, Kaohsiung, Taiwan, R.O.C.
  • Center for Health Data Science, Chung Shan Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.
  • Department of Clinical Pathology, Chi Mei Medical Center, Tainan, Taiwan, R.O.C.

Zitieren

APA

Huang, Y. N., Chiang, S. L., Huang, J. Y., Lu, W. L., Bau, D. T., Su, P. H., & Wang, C. H. (2024). The Long-term Lung and Respiratory Outcomes of Acid Sphingomyelinase Deficiency: A 10- and 20-year Follow-up Study. In Vivo. https://doi.org/10.21873/invivo.13457

Vancouver

Huang YN, Chiang SL, Huang JY, Lu WL, Bau DT, Su PH, et al. The Long-term Lung and Respiratory Outcomes of Acid Sphingomyelinase Deficiency: A 10- and 20-year Follow-up Study. In Vivo. 2024. doi:10.21873/invivo.13457

BibTeX
@article{Huang2024,
  author = {Huang, Yu-Nan and Chiang, Shang-Lun and Huang, Jing-Yang and Lu, Wen-Li and Bau, DA-Tian and Su, Pen-Hua and Wang, Chung-Hsing},
  title = {The Long-term Lung and Respiratory Outcomes of Acid Sphingomyelinase Deficiency: A 10- and 20-year Follow-up Study},
  journal = {In Vivo},
  year = {2024},
  doi = {10.21873/invivo.13457}
}
Kostenlos starten →